North York General Hospital is a teaching hospital in Toronto, Ontario, Canada. Primarily serving the North York district, as well as southern York Region, it offers acute care, ambulatory and long-term services at multiple sites.

During the past decade, North York General Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 14 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 6 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North York General Hospital" #1 sponsor was "Sunnybrook Health Sciences Centre" with 10 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "NCIC Clinical Trials Group" with 7 trials sponsored, "The Hospital for Sick Children" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North York General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 7 trials as a collaborator, "North York General Hospital" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "Canadian Critical Care Trials Group" with 3 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 102 trials.

According to Clinical.Site data, the most researched conditions in "North York General Hospital" are "Breast Cancer" (9 trials), "Down Syndrome" (4 trials), "COVID-19" (3 trials), "Influenza" (3 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "North York General Hospital" in a lesser frequency.

Most popular intervention types in "North York General Hospital" are "Drug" (35 trials), "Other" (27 trials), "Biological" (8 trials), "Procedure" (8 trials) and "Behavioral" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Prednisone" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "North York General Hospital" are 62 trials for "All" genders, 18 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "North York General Hospital". undefined are not yet recruiting, 13 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in North York General Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in North York General Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 22 trials that are defined as “Not Applicable".